Congratulations to Dr. Cheng for being named the Alan L. Kaganov Professor of Biomedical Engineering! Created through a generous gift by Carol M. Kaganov (Kaufman) to honor her late husband, Alan, the Alan L. Kaganov Professorship supports outstanding scholars who work in the field of biomedical engineering, with a special focus on pulmonary and/or cardiovascular systems.Continue reading “Dr. Cheng named the Alan L. Kaganov Professor of Biomedical Engineering.”
Author Archives: Ke Cheng
Dr. Cheng was awarded “Highly Cited Researcher 2023”.
Congratulations to Dr. Cheng for being recognized among the 2023 Highly Cited Researchers from Clarivate! 🎉 https://clarivate.com/highly-cited-researchers/ https://www.webofscience.com/wos/author/record/HCH-8846-2022
Dr. Cheng is elected to be a BMES Fellow!
The Fellow grade of membership is a prestigious honor recognizing outstanding achievement in biomedical engineering. Fellows have demonstrated impactful achievements and made significant contributions to the biomedical engineering community and to BMES. They are active leaders in the profession and within the Society. Dr. Ke Cheng was recognized for his contributions in translating adult stemContinue reading “Dr. Cheng is elected to be a BMES Fellow!”
Panos matched into UNC residency. Congratulations!
Dr. Panagiotis Tasoudis is a postdoc research fellow in our lab and he just got matched into UNC cardiothoracic surgery residency. Congratulations and good luck to your residency!
Our new paper on Nature Materials is online!
In this work, we report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel, named spherical hydrogel inhalation for enhanced lung defence (SHIELD). Good job Xuan & Junlang! Link: https://doi.org/10.1038/s41563-023-01475-7
Congrats to Zhenzhen! Our new paper on COVID-19 has been published on Nature Biomedical Engineering with a beautiful cover image.
The cover of our new paper in Nature Biomedical Engineering illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain. https://doi.org/10.1038/s41551-022-00902-5
Dr. Ke Cheng will serve as the Chair for the NIH Biomaterials and Biointerfaces (BMBI) study section for 2022-2024.
Congratulations!!
Congrats! Our paper developing ‘Nanodecoy’ therapy for COVID-19 is finally published on Nature Nanotechnology!
Our paper recently published in @NatureNano develops ‘Nanodecoy’ therapy which can trick and trap SARS-CoV-2 virus. Link to the paper: https://doi.org/10.1038/s41565-021-00923-2 Congrats to Zhenhua, Zhenzhen and Uyen! Check it out in this video:
Dr. Cheng is elected to be a Fellow of the International Academy of Medical and Biological Engineering (IAMBE)
This honor is in recognition of a scientist’s distinguished contributions to and leadership in the field of medical and biological engineering in an international level. http://www.iambe-ifmbe.org/ Way to go, more to come…
BioTherapeutics Lab 